New leadership aims to strengthen clinical standards and interdisciplinary collaboration in longevity medicine.
Healthy Longevity Medicine Society (HLMS) is an international organization dedicated to advancing the clinical application of longevity medicine through evidence-based practice, professional education and interdisciplinary collaboration. Bringing together physicians, scientists and industry leaders, HLMS seeks to establish rigorous standards for longevity interventions; its initiatives encompass training programs, clinical guidelines and partnerships designed to bridge the gap between research and medical application.
Dr Evelyne Bischof, a specialist in longevity and precision medicine, has been appointed President of HLMS, a role in which she will oversee the society’s strategic direction and engagement with the broader medical community. In addition, Professor Andrea Maier remains as an active past president – an apposite arrangement given they were both founders of the Society.
A physician with extensive experience in internal medicine and oncology, Bischof has held academic and clinical positions at institutions including Shanghai University and the University of Zurich; her work has focused on integrating emerging longevity interventions into mainstream clinical practice. In her new role, she will lead efforts to promote ethical, evidence-based approaches to longevity medicine, ensuring that advancements translate effectively into patient care.
Longevity.Technology: The appointment of Evelyne Bischof as President of HLMS marks a significant step in the formalization of longevity medicine as a clinical discipline; as a field that often straddles the boundary between innovation and regulation, longevity medicine requires clear frameworks to ensure that treatments are both safe and effective. Bischof’s background in internal medicine and her active engagement in academic and clinical research suggest that her leadership will bring both scientific rigor and practical insight to HLMS’s initiatives; her experience in multiple healthcare systems may also facilitate international consensus on best practices.
As longevity interventions become increasingly accessible, Bischof’s presidency could further establish HLMS as a key authority in guiding practitioners, fostering interdisciplinary collaboration and shaping ethical standards in this rapidly evolving domain. We sat down with her to find out more about HLMS’s vision and its future plans in this evolving field.
There is a critical need for standardized biological age assessment protocols in healthy longevity medicine – and this is something both Bischof and the wider team at HLMS are acutely aware of.
“Currently, clinics are using different biomarkers and methodologies, leading to inconsistencies in clinical practice and communication with clients/patients,” she explains. “Therefore, HLMS is currently developing a guideline together with the Biomarkers of Aging Consortium about the use of epigenetic clocks. HLMS aims to collaborate with experts, researchers, and regulatory bodies to establish evidence-based, clinically validated frameworks for measuring biological age.” Bischof adds that a standardized protocol would enhance comparability, reliability and clinical application, ensuring consistency across the sector.
Of course, several interventions used by clinics lack a solid evidence base. Many respondents to our Longevity Clinics Survey are jumping into these areas, but this could open up the sector to high-street clinics jumping into the next fad without any medical reasoning.
Bischof says it all comes down to evidence. “HLMS strongly advocates for evidence-based practice in healthy longevity medicine,” she explains. “While innovation is important, interventions must be supported by robust scientific data to ensure safety and efficacy. The growing popularity of longevity treatments without sufficient clinical validation poses a risk to patient safety and the credibility of the field.”
She explains that HLMS supports rigorous research, clinical trials and peer-reviewed data before recommending any intervention, and it also recognizes the need for regulatory oversight to prevent unproven or misleading therapies from entering the mainstream market.
This all warrants the need for longevity clinic practice/client management systems that align with an HLMS-approved client/patient protocol to ensure continuity of care, and Bischof says that HLMS acknowledges the importance of standardized electronic health record (EHR) and client management systems tailored for longevity clinics.
“Without a unified approach, data fragmentation and lack of continuity could hinder patient care,” she explains. “HLMS is exploring collaborations with health IT developers and regulatory bodies to establish guidelines for integrated, interoperable systems that can track biological age progression and patient interventions, ensure data security, regulatory compliance (GDPR, HIPAA) and facilitate longitudinal studies and real-world evidence collection. This will allow longevity clinics to deliver personalized, data-driven interventions while maintaining consistency across different practitioners and institutions.”
Many of our survey respondents were open to anonymously sharing client/patient data to improve outcomes – something that while incredibly important, poses both a regulatory and technical challenge. Setting standards for something like this would be something HLMS could take on in the future, as Bischof explains.
“HLMS recognizes the potential of big data and AI-driven insights in longevity medicine,” she says. “However, patient data security, consent, and compliance with ethical standards are paramount. HLMS could play a role in developing ethical guidelines for anonymized patient data sharing, advocating for secure data infrastructure that aligns with global regulations and facilitating collaborations between clinics, researchers, and regulators to ensure responsible data use.” Bischof says that by establishing clear frameworks of registries, HLMS can help longevity clinics leverage data for improved patient outcomes while maintaining trust and regulatory compliance.
Nearly 75% of respondents to our survey said they pursued CME-accredited courses in healthy longevity medicine, and Bischof explains that while this promising, the field is still evolving, and standardization remains a challenge.
“HLMS sees an opportunity to refine and elevate educational standards, ensuring that longevity medicine training is scientifically rigorous and updated with the latest research, covers both preventive and interventional aspects of healthy longevity medicine and includes clinical application frameworks that practitioners can integrate into patient care,” she explains, pointing out that HLMS’s role is to establish accreditation frameworks of longevity education programs to ensure a robust, evidence-based approach.
Longevity clinics are focusing more and more on prevention, and Bischof says that preventative strategies are central to healthy longevity medicine – whatever the age.
“HLMS engages with younger populations – particularly Millennials and Gen Z – and this can yield significant long-term health benefits,” she explains. “Our key approaches include public health initiatives to increase awareness of biological aging and lifestyle interventions and screening and early intervention programs to address metabolic, cardiovascular and cognitive risk factors early.” HLMS also encourages proactive engagement with longevity-focused health behaviors such as personalized nutrition, exercise and sleep optimization, and aims to collaborate with educational institutions, digital health platforms, and policy makers to drive a proactive, preventative longevity culture.
A hot topic at the moments is the development and promotion of standardized clinical guidelines and protocols for longevity medicine – but it is an initiative that needs consistency and quality of care across the sector.
Bischof explains that HLMS recognizes the urgent need for standardized clinical guidelines in healthy longevity medicine, and will play a role in their development.
“As the field grows, ensuring evidence-based, high-quality care is essential,” she explains, adding that HLMS aims to define key clinical protocols for patient assessment, biological age tracking and intervention efficacy.
“We also aim to standardize best practices to reduce variability across longevity clinics and collaborate with regulatory bodies and researchers to ensure guidelines evolve with new scientific discoveries,” she says. “By implementing structured guidelines, HLMS can help longevity clinics deliver more consistent, reliable, and ethical care across the sector.”
8. What opportunities does HLMS see for fostering collaborations and sharing best practices between private and public longevity clinics? Could a structured framework for exchanging knowledge enhance outcomes and drive innovation in the field?
Bischof says that HLMS strongly supports collaborative knowledge-sharing between private and public longevity clinics.
“The field of longevity medicine benefits from cross-sector partnerships that facilitate data-sharing initiatives to improve clinical research and create standardized outcome measures to compare intervention efficacy,” she says. “We need to establish global best practices through research collaborations and expert consensus and encourage joint clinical trials and pilot programs that bridge the gap between academic research and real-world practice.”
She adds that a structured framework for collaboration can accelerate innovation, enhance patient care and ensure longevity medicine remains an evidence-based, high-impact field.
Bischof says that HLMS is well-positioned to shape the future of healthy longevity medicine through standardization, regulatory guidance, clinical protocols, and collaborative research efforts.
“Establishing biological age assessment criteria, ensuring evidence-based interventions, promoting longevity-focused education, and fostering knowledge-sharing across public and private institutions will be key priorities in advancing the sector responsibly and effectively.”
